Cost-Effectiveness Analysis of Oral Anticoagulants in Stroke Prevention among Patients with Atrial Fibrillation in Taiwan

BACKGROUND: Non-vitamin K oral antagonist anticoagulants (NOACs) have been widely used in stroke prevention in atrial fibrillation (SPAF). The aim of this study was to compare the pharmacoeconomic impact of oral anticoagulants (OACs) including warfarin, dabigatran, rivaroxaban, apixaban, and edoxaba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Cardiol Sin
Main Authors: Liao, Chia-Te, Lee, Mei-Chuan, Chen, Zhih-Cherng, Ku, Li-Jung Elizabeth, Wang, Jung-Der, Toh, Han Siong
Formato: Artigo
Idioma:Inglês
Publicado em: Taiwan Society of Cardiology 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933494/
https://ncbi.nlm.nih.gov/pubmed/31903008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.202001_36(1).20190511A
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados